Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Acute Kidney Injury Treatment Market Overview Acute kidney injury (AKI) is a sudden episode of kidney failure/damage that can range from minor loss of kidney functions to complete kidney failure.

Objective To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI). Design Multicenter cohort study. Setting Six geographically diverse major ...

Acute kidney injury is common in hospitalised children and is associated with poor patient outcomes. Once acute kidney injury occurs, effective therapies to improve patient outcomes or kidney recovery ...

Acute kidney injury, acute kidney diseases and disorders, and chronic kidney disease are discussed in this second article in a series about the renal system.

Acute kidney injury, which doctors also refer to as acute renal failure (ARF), is an abrupt form of renal insufficiency where kidney function declines sharply over a short period.

Objective: The epidemiology and outcomes of acute kidney disease (AKD) after acute kidney injury (AKI) in hospitalized children are poorly described. The aim of this study is to investigate the ...

Table 1. Neonatal acute kidney injury diagnostic criteria. While the development and utilization of the neonatal modified KDIGO definition has driven the advancements in the field over the last 5–10 ...

Extracorporeal kidney-replacement therapy is provided as conventional or prolonged intermittent hemodialysis or as one of the forms of continuous kidney-replacement therapy (Figure 2 and Table 1).

We are reporting a case of acute kidney injury induced by levetiracetam for a patient with history of epilepsy who presented to emergency room with status epilepticus.

Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA ...